Article
Factbox: GSK beats Pfizer, other rivals to win RSV vaccine race
Rating:
0.0
Views:
59
Likes:
1
Library:
1
British drugmaker GSK Plc on Wednesday became the first to receive approval for its respiratory syncytial virus (RSV) vaccine in the United States, putting it ahead of rivals Pfizer Inc , Moderna Inc and Bavarian Nordic .
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value